MEPS HC 249: 2023 Medical Conditions
August 2025
Agency for Healthcare Research and Quality
Center for Financing, Access, and Cost Trends
5600 Fishers Lane Rockville, MD 20857
(301) 427-1406
Table of Contents
A. Data Use Agreement
B. Background
1.0 Household Component
2.0 Medical Provider Component
3.0 Survey Management and Data Collection
C. Technical and Programming Information
1.0 General Information
2.0 Data File Information
2.1 Codebook Structure
2.2 Reserved Codes
2.3 Codebook Format
2.4 Variable Naming
2.5 File Contents
2.5.1 Identifier Variables (DUID-CONDRN)
2.5.2 Medical Condition Variables (AGEDIAG-ICD10CDX)
2.5.3 Utilization Variables (OBCOND - RXCOND)
3.0 Survey Sample Information
3.1 Discussion of Pandemic Effects on Quality of MEPS Data
3.2 Sample Weight (PERWT23F)
3.3 Details on Person Weight Construction
3.3.1 MEPS Panel 27 Weight Development Process
3.3.2 MEPS Panel 28 Weight Development Process
3.3.3 The Final Weight for 2023
3.4 Coverage
3.5 Using MEPS Data for Trend Analysis
4.0 National Health Interview Survey (NHIS)
5.0 Longitudinal Analysis
References
D. Variable-Source Crosswalk
Appendix 1 ICD10CDX and CCSR Condition Code Frequencies
Individual identifiers have been removed from the micro-data contained in these files. Nevertheless, under Sections 308 (d) and 903 (c) of the Public Health Service Act (42 U.S.C. 242m and 42 U.S.C. 299 a-1), data collected by the Agency for Healthcare Research and Quality (AHRQ) and/or the National Center for Health Statistics (NCHS) may not be used for any purpose other than for the purpose for which they were supplied; any effort to determine the identity of any reported cases is prohibited by law.
Therefore in accordance with the above referenced Federal Statute, it is understood that:
- No one is to use the data in this dataset in any way except for statistical reporting and analysis; and
- If the identity of any person or establishment should be discovered inadvertently, then (a) no use will be made of this knowledge, (b) the Director Office of Management AHRQ will be advised of this incident, (c) the information that would identify any individual or establishment will be safeguarded or destroyed, as requested by AHRQ, and (d) no one else will be informed of the discovered identity; and
- No one will attempt to link this dataset with individually identifiable records from any datasets other than the Medical Expenditure Panel Survey or the National Health Interview Survey. Furthermore, linkage of the Medical Expenditure Panel Survey and the National Health Interview Survey may not occur outside the AHRQ Data Center, NCHS Research Data Center (RDC) or the U.S. Census RDC network.
By using these data you signify your agreement to comply with the above stated statutorily based requirements with the knowledge that deliberately making a false statement in any matter within the jurisdiction of any department or agency of the Federal Government violates Title 18 part 1 Chapter 47 Section 1001 and is punishable by a fine of up to $10,000 or up to 5 years in prison.
The Agency for Healthcare Research and Quality requests that users cite AHRQ and the Medical Expenditure Panel Survey as the data source in any publications or research based upon these data.
Return To Table Of Contents
The Medical Expenditure Panel Survey (MEPS) provides nationally representative estimates of health care use, expenditures, sources of payment, and health insurance coverage for the U.S. civilian
noninstitutionalized population. The MEPS Household Component (HC) also provides estimates of respondents’ health status, demographic and socioeconomic characteristics, employment, access to care, and satisfaction with care. Estimates can be produced for individuals, families, and selected population subgroups. The panel design of the survey includes five rounds of interviews covering 2 full calendar years. Information about each household member is collected through computer-assisted personal interviewing (CAPI) technology, and the survey builds on this information from interview to interview. All data for a sampled household are reported by a single household respondent.
The MEPS HC was initiated in 1996. Each year, a new panel of sample households is selected. Because the data collected are comparable to those from earlier medical expenditure surveys conducted in 1977 and 1987, it is possible to analyze long-term trends. Historically, each annual MEPS HC sample consists of up to 15,000 households. Data can be analyzed at the person, the family, or the event level. Data must be weighted to produce national estimates.
The set of households selected for each panel of the MEPS HC is a subsample of households participating in the previous year’s National Health Interview Survey (NHIS) conducted by the National Center for Health Statistics (NCHS). The NHIS sampling frame provides a nationally representative sample of the U.S. civilian noninstitutionalized population. In 2006, the NCHS implemented a new sample design for the NHIS to include households with Asian persons in addition to households with Black and Hispanic persons in the oversampling of minority populations. In 2016, NCHS introduced another sample design that discontinued the oversampling of these minority groups.
Return To Table Of Contents
When the household CAPI interview is completed, and permission is obtained from the sample members to contact their medical provider(s), a sample of these providers is contacted by telephone to obtain information that household respondents cannot accurately provide. This part of the MEPS is called the Medical Provider Component (MPC), and it collects information on dates of visits, diagnosis and procedure codes, and charges and payments. The Pharmacy Component (PC), a subcomponent of the MPC, does not collect data on charges or on diagnosis and procedure codes, but it does collect detailed information on drugs, including the National Drug Code (NDC) and medicine name, as well as amounts of payment. The MPC is not designed to yield national estimates. It is primarily used as an imputation source to supplement/replace household reported expenditure information.
Return To Table Of Contents
MEPS HC and MPC data are collected under the authority of the Public Health Service Act. The MEPS HC data are collected under contract with Westat, Inc. and the MEPS MPC data are collected under contract with Research Triangle Institute. Datasets and summary statistics are edited and published in accordance with the confidentiality provisions of the Public Health Service Act and the Privacy Act. The NCHS provides consultation and technical assistance.
As soon as the MEPS data are collected and edited, they are released to the public in stages of microdata files and tables via the MEPS website and datatools.ahrq.gov.
Additional information on MEPS is available from the MEPS project manager or the MEPS public use data manager at the Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD 20857 (301-427-1406).
Return To Table Of Contents
This documentation describes the Medical Conditions Public Use File HC 249 (hereafter referred to as the Conditions PUF), which is one in a series of public use data files to be released from the 2023 Medical Expenditure Panel Survey Household Component (MEPS HC). It was released as an ASCII file (with related SAS, SPSS, R, and Stata programming statements and data user information), and as a SAS dataset, a SAS transport file, a Stata dataset, and an Excel file. The Conditions PUF provides information on household-reported medical conditions collected from a nationally representative sample of the U.S. civilian noninstitutionalized population for calendar year 2023 MEPS HC. It contains 29 variables and has a logical record length of 110 with an additional 2-byte carriage return/line feed at the end of each record.
This documentation offers a brief overview of the types and levels of data provided and a detailed description of the content and structure of the files. It is organized into the following sections:
- Data File Information (Section 2.0)
- Survey Sample Information (Section 3.0)
- National Health Interview Survey (Section 4.0)
- Longitudinal Analysis (Section 5.0)
- Variable-Source Crosswalk (Section D)
- Appendix: ICD10CDX and CCSR Condition Code Frequencies (Appendix 1)
A codebook of all the variables included in the 2023 Conditions PUF is provided in an accompanying file.
For more information on the MEPS sample design, see Chowdhury et al. (2019). A copy of the survey instrument used to collect the information in this PUF is available on the MEPS website.
Return To Table Of Contents
This PUF contains 63,656 records. Each record represents one current medical condition reported for a household survey member who resides in an eligible responding household and who has a positive person or family weight. A condition is defined as current if it is linked to an event during 2023. Conditions in the Priority Condition Enumeration (PE) section are asked in the context of “has (person) ever been told by a doctor or other health care professional that they have (condition)?” except joint pain and chronic bronchitis, which asks only about the last 12 months. Persons with a response of Yes (1) to a priority condition question for whom the condition is not current as defined above will not have a record for that condition in this PUF.
This PUF consists of MEPS survey data obtained in Rounds 3, 4, and 5 of Panel 27, and Rounds 1, 2, and 3 of Panel 28, the rounds for the MEPS panels covering calendar year 2023.
For most variables on the file, the codebook provides both weighted and unweighted frequencies. The exceptions to this are weight variables and variance estimation variables. Only unweighted frequencies of these variables are included in the accompanying codebook file. See the Weights Variables list in Section D: Variable-Source Crosswalk.
Person-level data (e.g., demographic or health insurance characteristics) from the 2023 MEPS Full Year Consolidated file (HC 251) can be merged to the records in this file using DUPERSID. Since each record represents a single condition reported by a household respondent, some household members may have multiple medical conditions and thus will be represented by multiple records on this file. Other household members may have had no reported medical conditions and thus will have no records on this file. Still other household members may have had a reported medical condition that did not meet the criteria above and thus will have no records on this file. Data from this file also can be merged to 2023 MEPS Event Files (HC 248A, and HC 248D through HC 248H) by using the link files provided in HC 248I. (See HC 248I documentation for details.)
Return To Table Of Contents
The codebook and data file list variables in the following order:
- Unique person identifiers
- Unique condition identifiers
- Medical condition variables
- Utilization variables
- Weight and variance estimation variables
Note that the person identifier is unique within this data year.
Return To Table Of Contents
This Conditions PUF contains several reserved code values.
Table 1 Reserved Code Values, Labels, and Definitions
Value |
Label |
Definition |
-1 |
Inapplicable |
Question was not asked due to skip pattern |
-7 |
Refused |
Question was asked and respondent refused to answer question |
-8 |
Don’t know |
Question was asked and respondent did not know answer or the information could not be ascertained |
-15 |
Cannot be computed |
Value cannot be derived from data |
The value Cannot be Computed (-15) was assigned to the MEPS constructed variables when there was not enough information from the instrument to calculate the constructed variables. Not having enough information is often the result of skip patterns in the data or of missing information stemming from the responses Refused (-7) or Don’t Know (-8). Note that, in addition to Don’t Know, reserved code -8 also includes cases for which the information from the question was Not Ascertained.
Return To Table Of Contents
This codebook describes an ASCII dataset (although the data are also being provided in an Excel file, a Stata dataset, a SAS dataset, and a SAS transport file), and provides the programming identifiers for each variable.
Table 2 Variable Programming Identifiers
Identifier |
Description |
Name |
Variable name |
Description |
Variable descriptor |
Format |
Number of bytes |
Type |
Type of data: numeric (indicated by NUM) or character (indicated by CHAR) |
Start |
Beginning column position of variable in record |
End |
Ending column position of variable in record |
Return To Table Of Contents
In general, the variable names reflect the content of
the variable, with an 8-character limitation. Edited variables end in an “X” and
are so noted in the variable label. (CONDIDX, which is an encrypted identifier
variable, also ends in an “X”.)
As the collection, universe, or categories of
variables were altered, the variable names have been appended with “_Myy” to
indicate the collection year in which the alterations took place. These
alterations are described in detail throughout this document.
Variables in this Conditions PUF were derived either
from the questionnaire itself or from the CAPI. The source of each variable is
identified in Section D: Variable-Source Crosswalk. Sources for each variable
are indicated in one of three ways:
- Variables derived from CAPI or assigned in sampling are so
indicated;
- Variables collected at one or more specific questions have
those numbers and questionnaire sections indicated in the
“Source” column; and
- Variables constructed from multiple questions by using
complex algorithms are labeled “Constructed” in the “Source”
column.
Return To Table Of Contents
The definitions of Dwelling Units (DUs) in the MEPS HC
are generally consistent with the definitions employed for the NHIS. The
Dwelling Unit ID (DUID) is a 7-digit ID number consisting of a 2-digit panel
number followed by a 5-digit random number assigned after the case was sampled
for MEPS. A 3-digit person number (PID) uniquely identifies each person within
the DU. The variable DUPERSID is the combination of the variables DUID and PID.
IDs begin with a 2-digit panel number.
CONDN is the condition number and uniquely identifies
each condition reported for an individual. A 3-digit CONDN beginning with “9”
reflects a condition that was added during the editing process. Note that
conditions are not added every year during editing. The range in this PUF for
CONDN is 1-46.
The variable CONDIDX uniquely identifies each
condition (i.e., each record in this PUF) and is the combination of DUPERSID and
CONDN. CONDIDX has a length of 13 with DUPERSID (10) and CONDN (3) combined.
PANEL is a constructed variable used to specify the
panel number for the interview in which the condition was reported. PANEL will
indicate Panel 27 or Panel 28. The panel number is included as the first two
digits of the DUID and DUPERSID.
CONDRN indicates the round in which the condition was
first reported. For a small number of cases, conditions that actually
began in an earlier round were not reported by respondents until subsequent
rounds of data collection. During file construction, editing was performed for
these cases in order to reconcile the round in which a condition began and the
round in which the condition was first reported.
Return To Table Of Contents
This PUF contains variables describing medical
conditions reported by respondents in several sections of the MEPS
questionnaire, and all questionnaire sections collecting information about
health provider visits and/or prescription medications (see Variable-Source
Crosswalk in Section D for details).
Priority Conditions and Injuries
Certain conditions were a priori designated as
“priority conditions” due to their prevalence, expense, or relevance to policy.
Some of these are long-term, life-threatening conditions, such as cancer,
diabetes, emphysema, high cholesterol, hypertension, ischemic heart disease, and
stroke. Others are chronic, manageable conditions, including arthritis and
asthma. The only mental health condition on the priority conditions list is
attention deficit hyperactivity disorder/attention deficit disorder.
When a condition was first mentioned, respondents were
asked whether it was due to an accident or injury (INJURY=1). Only non-priority
conditions (i.e., conditions reported in a section other than PE) are eligible
to be injuries. The interviewer is prevented from selecting priority conditions
as injuries.
Complete List of Conditions Asked in Priority
Conditions Enumeration Section:
- Arthritis
- Asthma
- ADHD/ADD
- Cancer
- Chronic bronchitis
- COVID-19 and Long COVID
- Diabetes
- Emphysema
- Heart Disease (including coronary heart disease, angina,
myocardial infarction, and other unspecified heart disease)
- High blood pressure, including multiple diagnoses
- High cholesterol
- Joint pain
- Stroke
Age Priority Condition Began
The age of diagnosis (AGEDIAG) was collected for all
priority conditions, except joint pain.
For confidentiality reasons, AGEDIAG is set to Inapplicable (-1) for
cancer conditions.
To ensure confidentiality,
age of diagnosis was top-coded to 85. This corresponds with the
age top-coding in person-level PUFs.
Follow-up Questions for Injuries
When a respondent reported that a condition resulted
from an accident or injury (INJURY=1), respondents were asked during the round
in which the injury was first reported whether the accident/injury occurred at
work (ACCDNWRK). This question was not asked about persons aged 15 and younger;
the condition had ACCDNWRK coded to inapplicable (-1) for those persons.
Sources for Conditions on the MEPS Conditions File
The records in this PUF correspond with medical
condition records collected by CAPI and stored on a person’s MEPS conditions
roster. Conditions can be added to the MEPS conditions roster in several ways. A
condition can be reported in the Priority Condition Enumeration (PE) section in
which persons are asked if they have been diagnosed with specific conditions.
The condition can be identified as the reason reported by the household
respondent for a particular medical event (hospital stay, outpatient visit,
emergency room visit, home health episode, prescribed medication purchase, or
office-based medical provider visit). Some condition information is collected in
the MPC of MEPS. However, since it is not available for everyone in the sample,
it is not used to supplement, replace, or verify household-reported condition
data. Conditions reported in the PE section that are not current are not
included in this PUF.
Treatment of Data from Rounds Not Occurring in 2023
Prior to the 2008 PUF, priority conditions reported
during Rounds 1 and 2 of the second year panel were included in the PUF even if
the conditions were not related to an event or reported as a serious condition
occurring in the second year of the panel. Beginning in 2008, priority
conditions are included in the PUF only if they are also current conditions.
From 2008-2017, a current condition was defined as a condition linked to an
event or a condition the person was currently experiencing (i.e., a condition
selected in the Condition Enumeration (CE) section). However, starting in Panel
21 Round 5 and Panel 22 Round 3, a current condition is defined only as a
condition linked to a current year event. Conditions from Panel 27 Rounds 1-3
that are not included in the 2023 PUF may be available in the 2022 Conditions
PUF if the person had a positive person or family weight in 2022.
Note: Priority conditions are generally chronic
conditions. Even though a person may not have reported an event in 2023 due to
the condition, analysts should consider that the person may still be
experiencing the condition. If a Panel 27 person reported a priority condition
in Round 1 or 2 and did not have an event for the condition in Round 3, 4, or 5,
the condition will not be included on the 2023 Medical Conditions PUF.
Rounds in Which Conditions Were Reported/Selected (CRND1 - CRND9)
A set of constructed variables indicates the round in
which the condition was first reported (CONDRN), and the subsequent round(s) in
which the condition was selected (CRND1 - CRND9). The condition may be reported
or selected when the person reports an event that occurred due to the condition.
For example, consider a condition for which CRND1 = 0, CRND2 = 1, and CRND3 = 1.
For non-priority conditions (conditions not asked in the PE section), this
sequence of indicators on a condition record implies that the condition was not
present during Round 1 (CRND1 = 0), was first mentioned during Round 2 (CRND2 =
1, CONDRN = 2), and was selected again during Round 3 (CRND3 = 1). For priority
conditions, this sequence of indicators implies that the condition was reported
in the PE section in Round 1 (CONDRN = 1, CRND1 = 0) but was not connected with
an event until Rounds 2 and 3 (CRND2 = 1, CRND3 = 1). Because priority
conditions are asked in the context of “has (person) ever been told by a doctor
or other health care professional that they have (condition)?” except joint pain
and chronic bronchitis, which ask only about the last 12 months, a priority
condition might not be selected in the round in which it was first reported. A
condition is current if it is linked to an event that occurred in 2023.
Diagnosis Codes
Medical conditions reported by the HC respondent were
recorded by the interviewer using a condition pick-list with ICD-10-CM codes
already assigned to conditions in the list. Reported conditions not in the
pick-list were recorded as verbatim text and then were coded to ICD-10-CM codes
(ICD10CDX) by professional coders.
Coders followed specific guidelines in coding missing
values to the ICD-10-CM diagnosis condition variable when a verbatim text string
could not be matched to an ICD-10-CM code through the pick-list. ICD10CDX was
coded -15 (Cannot be Computed) where the verbatim text fell into one of three
categories: (1) the text indicated that the condition was unknown (e.g., DK);
(2) the text indicated the condition could not be diagnosed by a doctor (e.g.,
doctor doesn’t know); or (3) the specified condition was not codable. If the
text indicated a procedure and the condition associated with the procedure could
be discerned from the text, the condition itself was coded. For example,
“cataract surgery” would be coded as the condition “other cataract” (ICD10CDX is
set to code “H26”). If the condition could not be discerned (e.g. “outpatient
surgery”), ICD10CDX was set to -15.
In order to preserve confidentiality, all of the
conditions provided in this PUF have been collapsed to 3-digit diagnosis code
categories rather than the fully-specified ICD-10-CM code. For example, the
ICD10CDX value of J02 “Acute pharyngitis” includes the fully-specified
subclassifications J020 and J029; the value F31 “Bipolar disorder” includes the
fully-specified subclassifications F3110 through F319. Table 1 in Appendix 1
provides unweighted and weighted frequencies for all ICD-10-CM condition code
values reported in the PUF. Less than 1 percent of the ICD-10-CM codes in this
PUF were edited further by collapsing two or more 3-digit codes into one 3-digit
code. This includes clinically rare conditions that were recoded to broader
codes by clinicians. A condition is determined to be clinically rare if it
appears on the
National Institutes of Health’s list of rare diseases.
For confidentiality purposes, approximately 11.5%
of ICD-10-CM codes were recoded to -15 (Cannot be Computed) for conditions
where the frequency was fewer than 40 for the total unweighted population in the
PUF or less than 400,000 for the weighted population. Additional factors used to
determine recoding include age and sex.
In a small number of cases, diagnosis and condition
codes were recoded to Cannot be Computed (-15) if they denoted a pregnancy for a
person younger than 18 or older than 44. Less than one-tenth of 1 percent of
records were recoded in this manner on the 2023 Conditions PUF. The person’s age
was determined by linking the 2023 Conditions PUF to the 2022 and 2023
Population Characteristics PUF. If the person’s age is under 18 or over 44 in
the round in which the pregnancy-related condition was reported, the
pregnancy-related condition code was recoded to Cannot be Computed (-15).
Users should note that because of the design of the
survey, most deliveries (i.e., births) are coded as pregnancies. For more
accurate estimates for deliveries, analysts should use RSNINHOS “Reason Entered
Hospital” found on the Hospital Inpatient Stays PUF (HC 248D).
Conditions PUF data can be merged with the 2023 Event
PUFs using the 2023 Condition-Event Link PUF (HC 248I). Because the conditions
have been collapsed to 3-digit diagnosis code categories rather than the
fully-specified ICD-10-CM code, it is possible for there to be duplicate
ICD-10-CM condition codes linked to a single medical event when different
fully-specified conditions are collapsed to the same 3-digit code.
Conditions were reported in several sections of the HC
questionnaire (see Variable-Source Crosswalk in Section D). Labels for all
values of ICD10CDX, as shown in Table 1 of Appendix 1, are provided in the SAS
programming statements included in this release (see the H249SU.TXT file).
Clinical Classification Software Refined
Clinical Classification Software Refined (CCSR) codes
are used alongside ICD-10-CM diagnosis codes to group medical conditions into
clinically meaningful categories. Although ICD-10-CM diagnosis codes can map to
multiple CCSR codes, for the purposes of this PUF, one ICD-10-CM diagnosis code
may map to up to four CCSR categories (CCSR1X, CCSR2X, CCSR3X, and CCSR4X using
the v2024.1 release of the CCSR for ICD-10-CM diagnoses. The CCSR codes on this
PUF are listed in alphabetical order and do not indicate a primary and secondary
diagnosis. For more information on CCSR, visit the
user guide for CCSR.
For confidentiality purposes, approximately 7.6% of
the CCSR categories were collapsed into a broader code for the appropriate body
system where the frequency was less than 40 for the total unweighted population
in the file or less than 400,000 for the weighted population. For example,
BLD001 (Nutritional Anemia), may be recoded to BLD000 (Disease of Blood and
Disorders Involving Immune Mechanism), thus revealing only the body system. Less
than one-tenth of 1% of CCSR codes were recoded to Cannot be
Computed (-15) based on frequencies of ICD10CDX and CCSR pairs.
Table 2 in Appendix 1 provides unweighted and weighted
frequencies for CCSR combinations reported in this PUF.
Return To Table Of Contents
The variables OBCOND, OPCOND, HHCOND, IPCOND and
ERCOND indicate that at least one 2023 event can be linked to the condition
record on the current file, i.e., office-based, outpatient, home health,
inpatient hospital stays and emergency room visits. Note that the HHCOND
variable includes all home health types, including informal care, and OBCOND and
OPCOND include telehealth visits. The variable RXCOND is an indicator of any
prescribed medicine purchase associated with the condition.
These event indicators were derived from Expenditure
Event PUFs (HC 248G, HC 248F, HC 248H, HC 248D, HC 248E, and HC 248A). Events
associated with conditions include all utilization that occurred between January
1, 2023 and December 31, 2023.
Return To Table Of Contents
Modification to the MEPS sample design because of the
pandemic ended in 2022. Concerns of potential bias due to these modifications
should no longer apply to data collected in this PUF. However, like most other
surveys, MEPS has been substantially affected by the pandemic. As a result of
these changes, potential bias continues to be a concern. One effect of the
pandemic is the significantly lower response rates (Section 3.2), and these
lower rates might differentially exclude households more likely to experience IP
stays. The demographic shifts on MEPS between 2019 and 2022 suggest a more
educated, higher-income, older MEPS sample. (For more detail, see Section 3.1 of
the
2020 Consolidated PUF, Section 3.1 of
the
2021 Consolidated PUF, and Section
3.1.2 of the
2022 Consolidated PUF.)
Analyses undertaken to examine the quality of the MEPS
FY 2023 data compare health care utilization and health insurance coverage for
the MEPS target population between the panels fielded. These comparisons were
undertaken for the full sample and the three age groups of 0-17, 18-64, and 65+.
These comparisons found no abnormal differences between the two panels. Analyses
across years also suggest a rebound to pre-pandemic utilization levels for most
key event types.
The various actions taken in the development of the person-level weights for
the MEPS FY 2023 data were designed to limit the potential for response bias.
However, analysts of the MEPS FY 2023 data should continue to exercise caution
when interpreting estimates and assessing analyses, especially for data collected
from 2020 through 2022. This includes the comparison of such estimates to those
of other years and corresponding trend analyses.
Return To Table Of Contents
There is a single full-year person-level weight
(PERWT23F) assigned to each record for each Key, in-scope person who responded
to MEPS for the full period of time that they were in scope during 2023. A Key
person was either a member of a responding NHIS household at the time of the
interview or joined a family associated with such a household after being out of
scope at the time of the NHIS (the latter circumstance includes newborns as well
as those returning from military service, an institution, or residence in a
foreign country). A person is in scope whenever they are a member of the
civilian noninstitutionalized portion of the U.S. population.
Return To Table Of Contents
The person-level weight PERWT23F was developed in
several stages. First, a person-level weight for Panel 27 was created, including
an adjustment for nonresponse over time and raking. The raking involved
adjusting to several sets of marginal control totals reflecting Current
Population Survey (CPS) population estimates based on six variables. The six
variables used in the establishment of the initial person-level control
figures were: educational
attainment of the reference person (three categories: no degree; high school/GED
only or some college; bachelor’s or a higher degree); Census region
(Northeast, Midwest, South, West); MSA status (MSA, non-MSA); race/ethnicity
(Hispanic; Black, non-Hispanic; Asian, non-Hispanic; and other); sex; and age
(0-18, 19-25, 26-34, 35-44, 45-64, and 65 or older). (Note for
confidentiality reasons, the MSA status variables are no longer released for
public use.) The person-level weight for Panel 28 was created similarly.
Secondly, a composite weight was formed by multiplying each weight from Panel 27
by the factor .40 and each weight from Panel 28 by the factor .60. The choice of
factors reflected the relative effective sample sizes of the two panels, helping
to limit the variance of estimates obtained from pooling both samples. Weights
for the 2023 Population Characteristics PUF were then developed by raking the
composite weight to the same set of CPS-based control totals.
The approach for establishing the 2023 Consolidated
PUF weight is as follows. When poverty status information derived from MEPS
income variables becomes available, a final raking is undertaken. The full
sample weight appearing on the Population Characteristics PUF for a given year
is re-raked, replacing educational attainment with poverty status while
retaining the other five raking variables previously indicated. Specifically,
control totals based on CPS estimates of poverty status (five categories: below
poverty, from 100 to 125 percent of poverty, from 125 to 200 percent of poverty,
from 200 to 400 percent of poverty, at least 400 percent of poverty) as well as
age, race/ethnicity, sex, region, and MSA status are used to calibrate weights.
Return To Table Of Contents
The person-level weight for MEPS Panel 27 was
developed by using the 2022 full-year weight as a “base” weight for survey
participants present in 2023.
For Key, in-scope members who joined an RU at some
time in 2023 after being out of scope in 2022, the initially assigned
person-level weight was the corresponding 2022 family weight. The weighting
process also included an adjustment for person-level nonresponse over Rounds 4
and 5 as well as raking to the population control figures for December 2023 for
Key, responding persons in scope on December 31, 2023. These control totals were
derived by scaling back the population distribution obtained from the March 2024
CPS to reflect the December 31, 2023 estimated population total (estimated based
on Census projections for January 1, 2024). Variables used for person-level
raking included: education of the reference person (no degree, high school/GED
only or some college, bachelor’s or a higher degree); Census region (Northeast,
Midwest, South, West); MSA status (MSA, non-MSA); race/ethnicity (Hispanic;
Black, non-Hispanic; Asian, non-Hispanic; and other); sex; and age. (Note for confidentiality reasons, the MSA status variables are no
longer released for public use.) The final weight for Key, responding persons
who were not in scope on December 31, 2023 but were in scope earlier in the year
was the nonresponse-adjusted person weight without raking.
Note that the 2022 full-year weight that was used as
the base weight for Panel 27 was derived using the 2022 MEPS Round 1 weight and
reflected adjustment for nonresponse over the remaining data collection rounds
in 2022 as well as raking to the December 2022 population control figures.
Return To Table Of Contents
The person-level weight for Panel 28 was developed
using the 2023 Round 1 person-level weight as a “base” weight. The Round 1
weights incorporated the following components: the original household
probability of selection for the NHIS and for the NHIS subsample reserved for
the MEPS, an adjustment for NHIS nonresponse, the probability of selection for
MEPS from the NHIS, an adjustment for nonresponse at the dwelling unit level for
Round 1, and raking to control figures at the person level obtained from the
March CPS of the corresponding year. For Key, in-scope members who joined an RU
after Round 1, the Round 1 DU weight served as a “base” weight.
The weighting process also included an adjustment for
nonresponse over the remaining data collection rounds in 2023 as well as raking
to the same population control figures for December 2023 that were used for the
Panel 27 weight for Key, responding persons in scope on December 31, 2023. The
same six variables used for Panel 27 raking (education level of the reference
person, Census region, MSA status, race/ethnicity, sex, and age) were also used
for Panel 28 raking. Similar to Panel 27, the Panel 28 final weight for Key,
responding persons who were not in scope on December 31, 2023 but were in scope
earlier in the year was the nonresponse-adjusted person weight without raking.
Return To Table Of Contents
The final raking of those in scope at the end of the
year has been described above. In addition, the composite weights of two groups
of persons who were out of scope on December 31, 2023 were adjusted for expected
undercoverage. Specifically, the weights of those who were out of scope on
December 31, 2023, but in scope at some time during the year and were residing
in a nursing home at the end of the year were poststratified to an estimate of
the number of persons who were residents of Medicare- and Medicaid-certified
nursing homes for part of the year (approximately 3-9 months) during 2014. This
estimate was developed from data on the Minimum Data Set (MDS) of the Center for
Medicare and Medicaid Services (CMS). The weights of persons who died while in
scope were poststratified to corresponding estimates derived using data obtained
from the Centers for Disease Control and Prevention (CDC), National Center for
Health Statistics (NCHS),
Provisional Mortality Statistics, 2018 through Last Week
on CDC WONDER
Online Database, released in 2024, the latest available data at the time.
Separate decedent control totals were developed for the “65 and older” and
“under 65” civilian noninstitutionalized populations.
Overall, the weighted population estimate for the
civilian noninstitutionalized population for December 31, 2023 is 330,710,135
(PERWT23F >0 and INSC1231=1). The sum of person-level weights across all persons
assigned a positive person-level weight is 334,530,273.
Return To Table Of Contents
The target population associated with MEPS is the 2023
U.S. civilian noninstitutionalized population. However, the MEPS sampled
households are a subsample of the NHIS households interviewed in 2021 (Panel 27)
and 2022 (Panel 28). New households created after the NHIS interviews for the
respective panels and consisting exclusively of persons who entered the target
population after 2021 (Panel 27) or after 2022 (Panel 28) are not covered by the
2023 MEPS. Nor are previously out of scope persons who joined an existing
household but are not related to the current household residents. Persons not
covered by a given MEPS panel thus include some members of the following groups:
immigrants, persons leaving the military, U.S. citizens returning from residence
in another country, and persons leaving institutions. Those not covered
represent a small proportion of the MEPS target population.
Return To Table Of Contents
For analysts using the MEPS data for trend analysis,
we note that there are uncertainties associated with 2020, 2021, and 2022 data
quality for reasons discussed throughout Section 3. Evaluations of important
MEPS estimates suggest that they are of reasonable quality. Nevertheless,
analysts are advised to exercise caution in interpreting these estimates,
particularly in terms of trend analyses, since access to health care was
substantially affected by the pandemic, as were related factors such as health
insurance and employment status for many persons.
The MEPS began in 1996, and the utility of the survey
for analyzing health care trends expands with each additional year of data;
however, when examining trends over time using the MEPS, the length of time
being analyzed should be considered. In particular, large shifts in survey
estimates over short periods of time (e.g. from one year to the next) that are
statistically significant should be interpreted with caution unless they are
attributable to known factors such as changes in public policy, economic
conditions, or the MEPS methodology.
With respect to methodological considerations, changes
in data collection methods, such as interviewer training, were introduced in
2013 to obtain more complete information about health care utilization from MEPS
respondents; the changes were fully implemented in 2014. This effort likely
resulted in improved data quality and a reduction in underreporting starting in
the second half of 2013 and continuing throughout the 2014 full year files; the
changes have also had some impact on analyses involving trends in utilization
across years. The changes in the NHIS sample design in 2016 and 2018 could also
potentially affect trend analyses. The new NHIS sample design is based on more
up-to-date information related to the distribution of housing units across the
United States. As a result, it can be expected to better cover the full civilian
noninstitutionalized population, the target population for MEPS, as well as many
of its subpopulations. Better coverage of the target population helps to reduce
the potential for bias in both NHIS and MEPS estimates.
Another change with the potential to affect trend
analyses involved major modifications to the MEPS instrument design and data
collection process, particularly in the events sections of the instrument. These
were introduced in the spring of 2018 and thus affected data beginning with
Round 1 of Panel 23, Round 3 of Panel 22, and Round 5 of Panel 21. Since the
full year 2017 MEPS files were established from data collected in Rounds 1-3 of
Panel 22 and Rounds 3-5 of Panel 21, they reflected two instrument designs. To
mitigate the effect of such differences within the same full-year file, the
Panel 22 Round 3 data and the Panel 21 Round 5 data were transformed to make
them as consistent as possible with data collected under the previous design.
The changes in the instrument were designed to make the data collection effort
more efficient and easier to administer. In addition, expectations were that
data on some items, such as those related to health care events, would be more
complete with the potential of identifying more events. Increases in service use
reported since the implementation of these changes are consistent with these
expectations. Analysts should be aware of the possible impacts of these
changes on the data and especially trend analyses that include the year 2018
because of the design transition.
Process changes, such as data editing and imputation,
may also affect trend analyses. For example, analysts should refer to Section
2.5.11: Utilization, Expenditures, and Sources of Payment Variables in the
Consolidated PUF (HC 251) and, for more detail, to the documentation for the
prescription drug file (HC 248A) when analyzing prescription drug spending over
time. As always, it is recommended that, before conducting trend analyses,
analysts should review relevant sections of the documentation for descriptions
of these types of changes that might affect the interpretation of changes over
time.
To smooth or stabilize trend analyses based on the
MEPS data, analysts may also wish to consider using statistical techniques such
as comparing pooled time periods (e.g. 1996-1997 versus 2011-2012), working with
moving averages, or using modeling techniques with several consecutive years of
the data.
Finally, statistical significance tests should be
conducted to assess the likelihood that observed trends are not attributable to
sampling variation. In addition, researchers should be aware of the impact of
multiple comparisons on Type I error. Without making appropriate allowance for
multiple comparisons, conducting numerous statistical significance tests of
trends will increase the likelihood of concluding that a change has taken place
when one has not.
Return To Table Of Contents
Data from this PUF can be used alone or in conjunction
with other PUFs for different analytic purposes. Each MEPS panel can also be
linked back to the previous years’ NHIS public use data files. For information
on MEPS/NHIS link files please see the
AHRQ website.
Return To Table Of Contents
Panel-specific longitudinal files can be downloaded
from the
data section of the MEPS website. For
each panel, the longitudinal file comprises the MEPS survey data obtained in
Rounds 1 through 5 of the panels and can be used to analyze changes over a
two-year period. Variables in the PUF pertaining to survey administration,
demographics, employment, health status, disability days, quality of care,
patient satisfaction, health insurance, and medical care use and expenditures
were obtained from the MEPS Consolidated PUF from the years covered by that
panel. For more details or to download the data files, please see Longitudinal
Data Files at the
AHRQ website.
Return To Table Of Contents
Bramlett, M.D., Dahlhamer, J.M., & Bose, J. (2021,
September).
Weighting Procedures and bias assessment for the 2020
National Health Interview Survey.
Hyattsville, MD: National Center for Health Statistics.
Chowdhury, S.R., Machlin, S.R. & Gwet, K.L. Sample
designs of the Medical Expenditure Panel Survey Household Component, 1996-2006
and 2007-2016. (2019, January)
Methodology Report #33. Rockville,
MD: Agency for Healthcare Research and Quality.
Cox, B. and Iachan, R. (1987). A Comparison of
Household and Provider Reports of Medical Conditions. Journal of the American
Statistical Association 82(400): 1013-18.
Dahlhamer, J.M., Bramlett, M.D., Maitland, A., &
Blumberg, S.J. (2021).
Preliminary evaluation of nonresponse bias due to the COVID-19 pandemic on
National Health Interview Survey estimates, April-June 2020.
Hyattsville, MD: National Center for Health Statistics.
Edwards, W. S., Winn, D. M., Kurlantzick, V., et al.
Evaluation of National Health Interview Survey Diagnostic Reporting. National
Center for Health Statistics, Vital Health 2(120). 1994.
Health Care Financing Administration (1980).
International Classification of Diseases, 9th Revision, Clinical
Modification (ICD-CM). Vol. 1. (Department of Health and Human Services Pub. No
(PHS) 80-1260). Department of Health and Human Services: U.S. Public Health
Services.
Johnson, Ayah E., and Sanchez, Maria Elena. (1993),
Household and Medical Reports on Medical Conditions: National Medical
Expenditure Survey. Journal of Economic and Social Measurement, 19,
199-223.
Lau, D.T., Sosa, P., Dasgupta, N., & He, H. (2021).
Impact
of the COVID-19 pandemic on Public Health Surveillance and Survey Data
Collections in the United States. American
Journal of Public Health, 111 (12), pp. 2118-2121.
Rothbaum, J. & Bee, A. (2021, May 3).
Coronavirus Infects Surveys, Too: Survey Nonresponse Bias and
the Coronavirus Pandemic. Washington, DC: U.S.
Census Bureau.
Rothbaum, J. & Bee, A. (2022, September 13).
How Has the Pandemic Continued to Affect Survey Response?
Using Administrative Data to Evaluate Nonresponse in the 2022 Current Population
Survey Annual Social and Economic Supplement.
Washington, DC: U.S. Census Bureau.
U.S. Census Bureau.
Current Population Survey: 2021 Annual Social and Economic
(ASEC) Supplement. (2021). Washington, DC:
Author.
Zuvekas, S.H. & Kashihara, D. (2021).
The impacts of
the COVID-19 pandemic on the Medical Expenditure Panel Survey.
American Journal of Public Health, 111 (12), pp. 2157-2166.
MEPS HC 249: 2023 MEDICAL CONDITIONS
UNIQUE IDENTIFIER VARIABLES
Variable |
Label |
Source |
DUID |
PANEL # + ENCRYPTED DU
IDENTIFIER |
Assigned In Sampling |
PID |
PERSON NUMBER |
Assigned In Sampling |
DUPERSID |
PERSON ID (DUID + PID) |
Assigned In Sampling |
CONDN |
CONDITION NUMBER |
CAPI Derived |
CONDIDX |
CONDITION ID |
CAPI Derived |
PANEL |
PANEL NUMBER |
Constructed |
CONDRN |
CONDITION ROUND NUMBER |
CAPI Derived |
Return To Table Of Contents
MEDICAL CONDITION VARIABLES
Variable |
Label |
Source1 |
AGEDIAG |
AGE WHEN DIAGNOSED |
PE section |
CRND1 |
HAS CONDITION
INFORMATION IN ROUND 1 |
Constructed |
CRND2 |
HAS CONDITION
INFORMATION IN ROUND 2 |
Constructed |
CRND3 |
HAS CONDITION
INFORMATION IN ROUND 3 |
Constructed |
CRND4 |
HAS CONDITION
INFORMATION IN ROUND 4 |
Constructed |
CRND5 |
HAS CONDITION
INFORMATION IN ROUND 5 |
Constructed |
INJURY |
WAS CONDITION DUE TO
ACCIDENT/INJURY |
AH80 |
ACCDNWRK |
DID ACCIDENT OCCUR AT
WORK |
AH90 |
ICD10CDX |
ICD-10-CM CODE FOR
CONDITION - EDITED |
HS40, ER30, OP60,
MV70, HH80, PM120, PE Section (Edited) |
CCSR1X |
CLINICAL
CLASSIFICATION REFINED CODE 1 EDITED |
HS40, ER30, OP60,
MV70, HH80, PM120, PE section (Edited) |
CCSR2X |
CLINICAL
CLASSIFICATION REFINED CODE 2 EDITED |
HS40, ER30, OP60,
MV70, HH80, PM120, PE section (Edited) |
CCSR3X |
CLINICAL
CLASSIFICATION REFINED CODE 3 EDITED |
HS40, ER30, OP60,
MV70, HH80, PM120, PE section (Edited) |
CCSR4X |
CLINICAL
CLASSIFICATION REFINED CODE 4 EDITED |
HS40, ER30, OP60,
MV70, HH80, PM120, PE section (Edited) |
1See the Household Component section under Survey Questionnaires on the MEPS home page for information on the MEPS HC
questionnaire sections shown in the Source column (e.g., PE).
Return To Table Of Contents
UTILIZATION VARIABLES
Variable |
Label |
Source |
HHCOND |
ANY HOME HEALTH EVENTS
ASSOC. W/ CONDITION? |
Constructed |
IPCOND |
ANY INPATIENT EVENTS
ASSOC. W/ CONDITION? |
Constructed |
OPCOND |
ANY OUTPATIENT EVENTS
ASSOC. W/ CONDITION? |
Constructed |
OBCOND |
ANY OFFICE-BASED
EVENTS ASSOC W/ CONDITION? |
Constructed |
ERCOND |
ANY ER EVENTS ASSOC.
W/ CONDITION? |
Constructed |
RXCOND |
ANY PRESCRIBED
MEDICINES ASSOC. W/ COND.? |
Constructed |
Return To Table Of Contents
WEIGHTS AND VARIANCE ESTIMATION VARIABLES
Variable |
Label |
Source |
PERWT23F |
EXPENDITURE FILE
PERSON WEIGHT, 2023 |
Constructed |
VARSTR |
VARIANCE ESTIMATION
STRATUM, 2023 |
Constructed |
VARPSU |
VARIANCE ESTIMATION
PSU, 2023 |
Constructed |
Return To Table Of Contents
Table 1 UNWEIGHTED AND WEIGHTED COUNT OF RECORDS FOR EACH VALUE OF ICD10CDX
ICD10CDX VALUE |
ICD10CDX LABEL |
UNWEIGHTED |
WEIGHTED BY perwt23f |
-15 |
CANNOT BE COMPUTED |
7557 |
123705702.87 |
A08 |
VIRAL AND OTHER SPECIFIED INTESTINAL INFECTIONS |
99 |
1921659.04 |
A49 |
BACTERIAL INFECTION OF UNSPECIFIED SITE |
91 |
1711816.77 |
B00 |
HERPESVIRAL [HERPES SIMPLEX] INFECTIONS |
91 |
1370651.69 |
B02 |
ZOSTER [HERPES ZOSTER] |
76 |
1294114.17 |
B07 |
VIRAL WARTS |
60 |
1096685.99 |
B34 |
VIRAL INFECTION OF UNSPECIFIED SITE |
92 |
1985398.84 |
B35 |
DERMATOPHYTOSIS |
115 |
1746357.18 |
B37 |
CANDIDIASIS |
44 |
716367.90 |
C18 |
MALIGNANT NEOPLASM OF COLON |
44 |
644341.00 |
C34 |
MALIGNANT NEOPLASM OF BRONCHUS AND LUNG |
42 |
599230.89 |
C43 |
MALIGNANT MELANOMA OF SKIN |
119 |
1803304.51 |
C44 |
OTHER AND UNSPECIFIED MALIGNANT NEOPLASM OF SKIN |
364 |
5101069.23 |
C50 |
MALIGNANT NEOPLASM OF BREAST |
189 |
2589736.64 |
C61 |
MALIGNANT NEOPLASM OF PROSTATE |
156 |
2101732.44 |
C67 |
MALIGNANT NEOPLASM OF BLADDER |
46 |
679301.94 |
C73 |
MALIGNANT NEOPLASM OF THYROID GLAND |
49 |
725908.24 |
C95 |
LEUKEMIA OF UNSPECIFIED CELL TYPE |
46 |
590810.83 |
D04 |
CARCINOMA IN SITU OF SKIN |
97 |
1492095.17 |
D22 |
MELANOCYTIC NEVI |
60 |
987575.77 |
D48 |
NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSP SITES |
58 |
787218.21 |
D49 |
NEOPLASMS OF UNSPECIFIED BEHAVIOR |
78 |
1331604.99 |
D50 |
IRON DEFICIENCY ANEMIA |
71 |
1057375.79 |
D64 |
OTHER ANEMIAS |
97 |
1513037.15 |
E03 |
OTHER HYPOTHYROIDISM |
773 |
12131185.81 |
E04 |
OTHER NONTOXIC GOITER |
103 |
1353809.02 |
E05 |
THYROTOXICOSIS [HYPERTHYROIDISM] |
138 |
1818758.05 |
E06 |
THYROIDITIS |
119 |
1807465.35 |
E07 |
OTHER DISORDERS OF THYROID |
213 |
3228685.47 |
E11 |
TYPE 2 DIABETES MELLITUS |
2009 |
28805030.81 |
E28 |
OVARIAN DYSFUNCTION |
49 |
968335.96 |
E29 |
TESTICULAR DYSFUNCTION |
56 |
930195.49 |
E34 |
OTHER ENDOCRINE DISORDERS |
86 |
1519600.46 |
E53 |
DEFICIENCY OF OTHER B GROUP VITAMINS |
85 |
1342776.81 |
E55 |
VITAMIN D DEFICIENCY |
294 |
4622089.29 |
E61 |
DEFICIENCY OF OTHER NUTRIENT ELEMENTS |
142 |
2145886.51 |
E66 |
OVERWEIGHT AND OBESITY |
158 |
2686782.11 |
E78 |
DISORDERS OF LIPOPROTEIN METABOLISM AND OTHER LIPIDEMIAS |
3626 |
51947051.04 |
E86 |
VOLUME DEPLETION |
61 |
866388.44 |
E87 |
OTHER DISORDERS OF FLUID, ELECTROLYTE AND ACID-BASE BALANCE |
251 |
3462928.53 |
F03 |
UNSPECIFIED DEMENTIA |
72 |
928744.38 |
F19 |
OTHER PSYCHOACTIVE SUBSTANCE RELATED DISORDERS |
52 |
777045.88 |
F20 |
SCHIZOPHRENIA |
44 |
631077.38 |
F31 |
BIPOLAR DISORDER |
180 |
2840325.45 |
F32 |
DEPRESSIVE EPISODE |
1557 |
26326011.15 |
F39 |
UNSPECIFIED MOOD [AFFECTIVE] DISORDER |
49 |
706918.63 |
F41 |
OTHER ANXIETY DISORDERS |
1791 |
30722316.44 |
F43 |
REACTION TO SEVERE STRESS, AND ADJUSTMENT DISORDERS |
402 |
6941095.07 |
F84 |
PERVASIVE DEVELOPMENTAL DISORDERS |
83 |
1699454.90 |
F90 |
ATTENTION-DEFICIT HYPERACTIVITY DISORDERS |
616 |
11722021.83 |
F99 |
MENTAL DISORDER, NOT OTHERWISE SPECIFIED |
243 |
4508424.61 |
G20 |
PARKINSON'S DISEASE |
53 |
704700.61 |
G25 |
OTHER EXTRAPYRAMIDAL AND MOVEMENT DISORDERS |
118 |
1536461.15 |
G40 |
EPILEPSY AND RECURRENT SEIZURES |
98 |
1501620.43 |
G43 |
MIGRAINE |
374 |
6889826.48 |
G45 |
TRANSIENT CEREBRAL ISCHEMIC ATTACKS AND RELATED SYNDROMES |
256 |
3365001.54 |
G47 |
SLEEP DISORDERS |
1089 |
15760382.16 |
G56 |
MONONEUROPATHIES OF UPPER LIMB |
102 |
1727442.07 |
G57 |
MONONEUROPATHIES OF LOWER LIMB |
79 |
1191634.37 |
G62 |
OTHER AND UNSPECIFIED POLYNEUROPATHIES |
183 |
2770474.15 |
G89 |
PAIN, NOT ELSEWHERE CLASSIFIED |
254 |
3768854.16 |
H04 |
DISORDERS OF LACRIMAL SYSTEM |
205 |
2768518.84 |
H10 |
CONJUNCTIVITIS |
146 |
2918914.81 |
H26 |
OTHER CATARACT |
507 |
6467572.81 |
H33 |
RETINAL DETACHMENTS AND BREAKS |
52 |
664087.57 |
H35 |
OTHER RETINAL DISORDERS |
222 |
3115124.40 |
H40 |
GLAUCOMA |
320 |
4267725.91 |
H44 |
DISORDERS OF GLOBE |
77 |
1109153.64 |
H52 |
DISORDERS OF REFRACTION AND ACCOMMODATION |
340 |
6345299.10 |
H53 |
VISUAL DISTURBANCES |
96 |
1497996.71 |
H54 |
BLINDNESS AND LOW VISION |
110 |
1663411.25 |
H57 |
OTHER DISORDERS OF EYE AND ADNEXA |
154 |
2382641.46 |
H61 |
OTHER DISORDERS OF EXTERNAL EAR |
88 |
1367679.41 |
H66 |
SUPPURATIVE AND UNSPECIFIED OTITIS MEDIA |
416 |
8403601.86 |
H91 |
OTHER AND UNSPECIFIED HEARING LOSS |
261 |
3925284.14 |
H92 |
OTALGIA AND EFFUSION OF EAR |
68 |
1111519.70 |
H93 |
OTHER DISORDERS OF EAR, NOT ELSEWHERE CLASSIFIED |
72 |
1049661.90 |
I10 |
ESSENTIAL (PRIMARY) HYPERTENSION |
4312 |
62750619.92 |
I20 |
ANGINA PECTORIS |
44 |
533977.67 |
I21 |
ACUTE MYOCARDIAL INFARCTION |
272 |
3850178.48 |
I25 |
CHRONIC ISCHEMIC HEART DISEASE |
509 |
6792683.27 |
I26 |
PULMONARY EMBOLISM |
43 |
669461.56 |
I38 |
ENDOCARDITIS, VALVE UNSPECIFIED |
89 |
1102175.64 |
I48 |
ATRIAL FIBRILLATION AND FLUTTER |
327 |
4595047.77 |
I49 |
OTHER CARDIAC ARRHYTHMIAS |
234 |
3360259.86 |
I50 |
HEART FAILURE |
118 |
1580921.95 |
I51 |
COMPLICATIONS AND ILL-DEFINED DESCRIPTIONS OF HEART DISEASE |
154 |
2154986.59 |
I63 |
CEREBRAL INFARCTION |
45 |
597242.40 |
I74 |
ARTERIAL EMBOLISM AND THROMBOSIS |
213 |
2858839.78 |
I95 |
HYPOTENSION |
57 |
841671.71 |
I99 |
OTHER AND UNSPECIFIED DISORDERS OF CIRCULATORY SYSTEM |
59 |
735311.05 |
J00 |
ACUTE NASOPHARYNGITIS [COMMON COLD] |
224 |
4212482.38 |
J02 |
ACUTE PHARYNGITIS |
513 |
10607162.37 |
J06 |
ACUTE UPPER RESP INFECTIONS OF MULTIPLE AND UNSP SITES |
78 |
1599001.27 |
J11 |
INFLUENZA DUE TO UNIDENTIFIED INFLUENZA VIRUS |
195 |
3788370.05 |
J18 |
PNEUMONIA, UNSPECIFIED ORGANISM |
210 |
3280684.42 |
J20 |
ACUTE BRONCHITIS |
49 |
825750.95 |
J30 |
VASOMOTOR AND ALLERGIC RHINITIS |
887 |
13446090.69 |
J32 |
CHRONIC SINUSITIS |
450 |
7882738.78 |
J34 |
OTHER AND UNSPECIFIED DISORDERS OF NOSE AND NASAL SINUSES |
141 |
2273416.66 |
J39 |
OTHER DISEASES OF UPPER RESPIRATORY TRACT |
66 |
1117072.88 |
J40 |
BRONCHITIS, NOT SPECIFIED AS ACUTE OR CHRONIC |
135 |
2370001.83 |
J42 |
UNSPECIFIED CHRONIC BRONCHITIS |
104 |
1536050.88 |
J43 |
EMPHYSEMA |
79 |
1074611.00 |
J44 |
OTHER CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
198 |
2543588.69 |
J45 |
ASTHMA |
1212 |
18970988.17 |
J98 |
OTHER RESPIRATORY DISORDERS |
185 |
3060522.26 |
K04 |
DISEASES OF PULP AND PERIAPICAL TISSUES |
84 |
1393350.44 |
K08 |
OTHER DISORDERS OF TEETH AND SUPPORTING STRUCTURES |
182 |
3255900.29 |
K21 |
GASTRO-ESOPHAGEAL REFLUX DISEASE |
1175 |
17536944.29 |
K22 |
OTHER DISEASES OF ESOPHAGUS |
70 |
879604.10 |
K25 |
GASTRIC ULCER |
51 |
674257.17 |
K29 |
GASTRITIS AND DUODENITIS |
88 |
1011163.41 |
K30 |
FUNCTIONAL DYSPEPSIA |
148 |
1934688.93 |
K31 |
OTHER DISEASES OF STOMACH AND DUODENUM |
76 |
1163390.81 |
K44 |
DIAPHRAGMATIC HERNIA |
52 |
706243.72 |
K46 |
UNSPECIFIED ABDOMINAL HERNIA |
74 |
1177221.54 |
K50 |
CROHN'S DISEASE [REGIONAL ENTERITIS] |
42 |
718269.11 |
K52 |
OTHER AND UNSP NONINFECTIVE GASTROENTERITIS AND COLITIS |
55 |
784715.18 |
K57 |
DIVERTICULAR DISEASE OF INTESTINE |
80 |
1178925.54 |
K58 |
IRRITABLE BOWEL SYNDROME |
84 |
1339462.99 |
K59 |
OTHER FUNCTIONAL INTESTINAL DISORDERS |
177 |
2698992.77 |
K63 |
OTHER DISEASES OF INTESTINE |
167 |
2441085.38 |
K64 |
HEMORRHOIDS AND PERIANAL VENOUS THROMBOSIS |
58 |
853808.09 |
K76 |
OTHER DISEASES OF LIVER |
97 |
1708307.51 |
K82 |
OTHER DISEASES OF GALLBLADDER |
48 |
807840.97 |
K92 |
OTHER DISEASES OF DIGESTIVE SYSTEM |
80 |
1386798.90 |
L03 |
CELLULITIS AND ACUTE LYMPHANGITIS |
59 |
868041.03 |
L08 |
OTHER LOCAL INFECTIONS OF SKIN AND SUBCUTANEOUS TISSUE |
139 |
2300320.75 |
L23 |
ALLERGIC CONTACT DERMATITIS |
97 |
1599080.19 |
L29 |
PRURITUS |
57 |
838424.92 |
L30 |
OTHER AND UNSPECIFIED DERMATITIS |
210 |
3803279.08 |
L40 |
PSORIASIS |
100 |
1608429.24 |
L60 |
NAIL DISORDERS |
169 |
2282032.42 |
L65 |
OTHER NONSCARRING HAIR LOSS |
76 |
1308122.25 |
L70 |
ACNE |
153 |
3378595.18 |
L71 |
ROSACEA |
61 |
798902.78 |
L72 |
FOLLICULAR CYSTS OF SKIN AND SUBCUTANEOUS TISSUE |
85 |
1336175.56 |
L98 |
OTH DISORDERS OF SKIN, SUBCU, NOT ELSEWHERE CLASSIFIED |
316 |
4787369.75 |
M06 |
OTHER RHEUMATOID ARTHRITIS |
332 |
4626607.72 |
M10 |
GOUT |
228 |
3279156.10 |
M17 |
OSTEOARTHRITIS OF KNEE |
127 |
1758887.28 |
M19 |
OTHER AND UNSPECIFIED OSTEOARTHRITIS |
1218 |
16989180.94 |
M21 |
OTHER ACQUIRED DEFORMITIES OF LIMBS |
67 |
936380.00 |
M25 |
OTHER JOINT DISORDER, NOT ELSEWHERE CLASSIFIED |
1525 |
23269630.70 |
M35 |
OTHER SYSTEMIC INVOLVEMENT OF CONNECTIVE TISSUE |
44 |
715087.60 |
M41 |
SCOLIOSIS |
69 |
1159489.72 |
M48 |
OTHER SPONDYLOPATHIES |
97 |
1231180.32 |
M50 |
CERVICAL DISC DISORDERS |
52 |
760451.21 |
M51 |
THORACIC, THORACOLUM, AND LUMBOSACRAL INTVRT DISC DISORDERS |
235 |
3285622.95 |
M53 |
OTHER AND UNSPECIFIED DORSOPATHIES, NOT ELSEWHERE CLASSIFIED |
129 |
1881846.30 |
M54 |
DORSALGIA |
1455 |
21404022.76 |
M62 |
OTHER DISORDERS OF MUSCLE |
197 |
3022493.41 |
M65 |
SYNOVITIS AND TENOSYNOVITIS |
46 |
557817.38 |
M71 |
OTHER BURSOPATHIES |
49 |
810358.36 |
M72 |
FIBROBLASTIC DISORDERS |
84 |
1141319.61 |
M75 |
SHOULDER LESIONS |
76 |
1036178.29 |
M77 |
OTHER ENTHESOPATHIES |
122 |
1738868.92 |
M79 |
OTH AND UNSP SOFT TISSUE DISORDERS, NOT ELSEWHERE CLASSIFIED |
873 |
12514475.77 |
M81 |
OSTEOPOROSIS WITHOUT CURRENT PATHOLOGICAL FRACTURE |
170 |
2199332.08 |
M85 |
OTHER DISORDERS OF BONE DENSITY AND STRUCTURE |
197 |
2582710.75 |
N18 |
CHRONIC KIDNEY DISEASE (CKD) |
41 |
555190.10 |
N19 |
UNSPECIFIED KIDNEY FAILURE |
89 |
1181696.98 |
N20 |
CALCULUS OF KIDNEY AND URETER |
167 |
2778669.76 |
N28 |
OTH DISORDERS OF KIDNEY AND URETER, NOT ELSEWHERE CLASSIFIED |
211 |
2936519.35 |
N30 |
CYSTITIS |
64 |
1016151.04 |
N32 |
OTHER DISORDERS OF BLADDER |
133 |
1844797.53 |
N39 |
OTHER DISORDERS OF URINARY SYSTEM |
575 |
8936707.82 |
N40 |
BENIGN PROSTATIC HYPERPLASIA |
280 |
3851695.87 |
N42 |
OTHER AND UNSPECIFIED DISORDERS OF PROSTATE |
99 |
1296608.50 |
N52 |
MALE ERECTILE DYSFUNCTION |
76 |
1176031.41 |
N63 |
UNSPECIFIED LUMP IN BREAST |
64 |
939842.33 |
N83 |
NONINFLAMMATORY DISORD OF OVARY, FALLOP AND BROAD LIGAMENT |
44 |
705359.80 |
N89 |
OTHER NONINFLAMMATORY DISORDERS OF VAGINA |
49 |
637523.84 |
N92 |
EXCESSIVE, FREQUENT AND IRREGULAR MENSTRUATION |
47 |
971322.78 |
R00 |
ABNORMALITIES OF HEART BEAT |
171 |
2344574.82 |
R01 |
CARDIAC MURMURS AND OTHER CARDIAC SOUNDS |
82 |
1098834.43 |
R03 |
ABNORMAL BLOOD-PRESSURE READING, WITHOUT DIAGNOSIS |
56 |
868076.60 |
R05 |
COUGH |
305 |
5074164.64 |
R06 |
ABNORMALITIES OF BREATHING |
204 |
2962463.47 |
R07 |
PAIN IN THROAT AND CHEST |
138 |
2331250.84 |
R09 |
OTH SYMPTOMS AND SIGNS INVOLVING THE CIRC AND RESP SYS |
52 |
832448.46 |
R10 |
ABDOMINAL AND PELVIC PAIN |
218 |
3490635.80 |
R11 |
NAUSEA AND VOMITING |
258 |
4223063.81 |
R12 |
HEARTBURN |
167 |
2488221.78 |
R19 |
OTH SYMPTOMS AND SIGNS INVOLVING THE DGSTV SYS AND ABDOMEN |
82 |
1152703.10 |
R20 |
DISTURBANCES OF SKIN SENSATION |
43 |
606764.92 |
R21 |
RASH AND OTHER NONSPECIFIC SKIN ERUPTION |
212 |
3323236.12 |
R22 |
LOCALIZED SWELLING, MASS AND LUMP OF SKIN, SUBCU |
58 |
939532.11 |
R25 |
ABNORMAL INVOLUNTARY MOVEMENTS |
128 |
1581243.12 |
R26 |
ABNORMALITIES OF GAIT AND MOBILITY |
80 |
1078019.83 |
R32 |
UNSPECIFIED URINARY INCONTINENCE |
139 |
1832398.79 |
R33 |
RETENTION OF URINE |
42 |
598944.84 |
R35 |
POLYURIA |
48 |
680203.09 |
R39 |
OTH AND UNSP SYMPTOMS AND SIGNS INVOLVING THE GU SYS |
42 |
669617.32 |
R41 |
OTH SYMPTOMS AND SIGNS W COGNITIVE FUNCTIONS AND AWARENESS |
114 |
1591410.79 |
R42 |
DIZZINESS AND GIDDINESS |
223 |
3050680.38 |
R45 |
SYMPTOMS AND SIGNS INVOLVING EMOTIONAL STATE |
49 |
832338.18 |
R47 |
SPEECH DISTURBANCES, NOT ELSEWHERE CLASSIFIED |
61 |
1234557.41 |
R50 |
FEVER OF OTHER AND UNKNOWN ORIGIN |
118 |
2142663.43 |
R51 |
HEADACHE |
130 |
1931297.19 |
R52 |
PAIN, UNSPECIFIED |
106 |
1721367.68 |
R53 |
MALAISE AND FATIGUE |
88 |
1306295.35 |
R54 |
AGE-RELATED PHYSICAL DEBILITY |
64 |
674383.93 |
R56 |
CONVULSIONS, NOT ELSEWHERE CLASSIFIED |
70 |
1006721.83 |
R60 |
EDEMA, NOT ELSEWHERE CLASSIFIED |
285 |
3678328.78 |
R63 |
SYMPTOMS AND SIGNS CONCERNING FOOD AND FLUID INTAKE |
69 |
1274931.50 |
R73 |
ELEVATED BLOOD GLUCOSE LEVEL |
235 |
3829458.46 |
R91 |
ABNORMAL FINDINGS ON DIAGNOSTIC IMAGING OF LUNG |
52 |
733659.06 |
S06 |
INTRACRANIAL INJURY |
66 |
1332312.91 |
S32 |
FRACTURE OF LUMBAR SPINE AND PELVIS |
45 |
700078.20 |
S39 |
OTH & UNSP INJURIES OF ABD, LOW BACK, PELV & EXTRN GENITALS |
104 |
1813862.03 |
S42 |
FRACTURE OF SHOULDER AND UPPER ARM |
56 |
1001783.52 |
S46 |
INJURY OF MUSCLE, FASCIA AND TENDON AT SHLDR/UP ARM |
42 |
699985.41 |
S49 |
OTHER AND UNSPECIFIED INJURIES OF SHOULDER AND UPPER ARM |
96 |
1561580.14 |
S61 |
OPEN WOUND OF WRIST, HAND AND FINGERS |
64 |
1055343.27 |
S62 |
FRACTURE AT WRIST AND HAND LEVEL |
88 |
1501050.68 |
S69 |
OTHER AND UNSPECIFIED INJURIES OF WRIST, HAND AND FINGER(S) |
70 |
1190283.13 |
S82 |
FRACTURE OF LOWER LEG, INCLUDING ANKLE |
78 |
1283588.66 |
S83 |
DISLOCATION AND SPRAIN OF JOINTS AND LIGAMENTS OF KNEE |
83 |
1362514.57 |
S89 |
OTHER AND UNSPECIFIED INJURIES OF LOWER LEG |
100 |
1463632.26 |
S92 |
FRACTURE OF FOOT AND TOE, EXCEPT ANKLE |
64 |
1077992.12 |
S93 |
DISLOC & SPRAIN OF JOINTS & LIGAMENTS AT ANKL, FT & TOE LEV |
76 |
1644270.31 |
S99 |
OTHER AND UNSPECIFIED INJURIES OF ANKLE AND FOOT |
68 |
1234043.87 |
T14 |
INJURY OF UNSPECIFIED BODY REGION |
274 |
4338098.10 |
T63 |
TOXIC EFFECT OF CONTACT WITH VENOMOUS ANIMALS AND PLANTS |
59 |
844446.41 |
T78 |
ADVERSE EFFECTS, NOT ELSEWHERE CLASSIFIED |
250 |
3677846.61 |
T88 |
OTH COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NEC |
44 |
625307.28 |
U07 |
EMERGENCY USE OF U07 |
642 |
10873114.83 |
U09 |
POST COVID-19 CONDITION |
82 |
1262161.05 |
Z00 |
ENCNTR FOR GENERAL EXAM W/O COMPLAINT, SUSP OR REPRTD DX |
335 |
6163414.05 |
Z01 |
ENCNTR FOR OTH SP EXAM W/O COMPLAINT, SUSPECTED OR REPRTD DX |
209 |
3381062.50 |
Z04 |
ENCOUNTER FOR EXAMINATION AND OBSERVATION FOR OTHER REASONS |
56 |
890116.19 |
Z09 |
ENCNTR FOR F/U EXAM AFT TRTMT FOR COND OTH THAN MALIG NEOPLM |
58 |
955946.54 |
Z12 |
ENCOUNTER FOR SCREENING FOR MALIGNANT NEOPLASMS |
255 |
3701289.87 |
Z13 |
ENCOUNTER FOR SCREENING FOR OTHER DISEASES AND DISORDERS |
174 |
2774741.91 |
Z23 |
ENCOUNTER FOR IMMUNIZATION |
327 |
4779961.36 |
Z29 |
ENCOUNTER FOR OTHER PROPHYLACTIC MEASURES |
126 |
1979762.83 |
Z30 |
ENCOUNTER FOR CONTRACEPTIVE MANAGEMENT |
287 |
6172580.51 |
Z34 |
ENCOUNTER FOR SUPERVISION OF NORMAL PREGNANCY |
218 |
4011462.90 |
Z38 |
LIVEBORN INFANTS ACCORDING TO PLACE OF BIRTH AND TYPE OF DEL |
42 |
1050966.49 |
Z63 |
OTH PROB REL TO PRIM SUPPORT GROUP, INC FAMILY CIRCUMSTANCES |
68 |
1243360.29 |
Z71 |
PERSONS ENCNTR HEALTH SERV FOR OTH CNSL AND MED ADVICE, NEC |
209 |
3526143.54 |
Z76 |
PERSONS ENCOUNTERING HEALTH SERVICES IN OTHER CIRCUMSTANCES |
241 |
3961532.32 |
Z78 |
OTHER SPECIFIED HEALTH STATUS |
118 |
1774847.29 |
Z79 |
LONG TERM (CURRENT) DRUG THERAPY |
274 |
3785965.07 |
Z91 |
PERSONAL RISK FACTORS, NOT ELSEWHERE CLASSIFIED |
70 |
1313810.77 |
Z95 |
PRESENCE OF CARDIAC AND VASCULAR IMPLANTS AND GRAFTS |
41 |
544158.45 |
Z96 |
PRESENCE OF OTHER FUNCTIONAL IMPLANTS |
186 |
2629363.55 |
Z97 |
PRESENCE OF OTHER DEVICES |
46 |
566574.41 |
|
|
63656 |
987503811.33 |
Return To Table Of Contents
Table 2 UNWEIGHTED AND WEIGHTED COUNT OF RECORDS FOR EACH VALUE OF CCSR COMBINATION
CCSR1X VALUE |
CCSR1X LABEL |
CCSR2X VALUE |
CCSR2X LABEL |
CCSR3X VALUE |
CCSR3X LABEL |
CCSR4X VALUE |
CCSR4X LABEL |
UNWEIGHTED |
WEIGHTED BY perwt23f |
-15 |
CANNOT BE COMPUTED |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
396 |
6343829.98 |
BLD000 |
DISEASES OF BLOOD AND DISORDERS INVOLVING IMMUNE MECHANIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
127 |
1925630.08 |
BLD000 |
DISEASES OF BLOOD AND DISORDERS INVOLVING IMMUNE MECHANIS |
CIR000 |
DISEASES OF THE CIRCULATORY SYSTEM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1 |
15219.34 |
BLD000 |
DISEASES OF BLOOD AND DISORDERS INVOLVING IMMUNE MECHANIS |
NEO000 |
NEOPLASMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
5 |
43346.94 |
BLD001 |
NUTRITIONAL ANEMIA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
71 |
1057375.79 |
BLD003 |
APLASTIC ANEMIA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
97 |
1513037.15 |
CIR000 |
DISEASES OF THE CIRCULATORY SYSTEM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
347 |
5214089.63 |
CIR000 |
DISEASES OF THE CIRCULATORY SYSTEM |
FAC000 |
FACTORS INFLUENCING HEALTH STATUS & CONTACT W/ HEALTH SER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
71 |
959292.82 |
CIR000 |
DISEASES OF THE CIRCULATORY SYSTEM |
MUS000 |
DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1 |
48918.89 |
CIR000 |
DISEASES OF THE CIRCULATORY SYSTEM |
PRG000 |
PREGNANCY, CHILDBIRTH AND THE PUERPERIUM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1 |
.00 |
CIR004 |
ENDOCARDITIS AND ENDOCARDIAL DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
89 |
1102175.64 |
CIR007 |
ESSENTIAL HYPERTENSION |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
4312 |
62750619.92 |
CIR009 |
ACUTE MYOCARDIAL INFARCTION |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
272 |
3850178.48 |
CIR011 |
CORONARY ATHEROSCLEROSIS AND OTHER HEART DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
553 |
7326660.94 |
CIR011 |
CORONARY ATHEROSCLEROSIS AND OTHER HEART DISEASE |
FAC009 |
IMPLANT, DEVICE OR GRAFT RELATED ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
41 |
544158.45 |
CIR012 |
NONSPECIFIC CHEST PAIN |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
138 |
2331250.84 |
CIR013 |
ACUTE PULMONARY EMBOLISM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
43 |
669461.56 |
CIR015 |
OTHER AND ILL-DEFINED HEART DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
154 |
2154986.59 |
CIR017 |
CARDIAC DYSRHYTHMIAS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
561 |
7955307.63 |
CIR019 |
HEART FAILURE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
118 |
1580921.95 |
CIR020 |
CEREBRAL INFARCTION |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
45 |
597242.40 |
CIR026 |
PERIPHERAL AND VISCERAL VASCULAR DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
52 |
744770.69 |
CIR030 |
AORTIC AND PERIPHERAL ARTERIAL EMBOLISM OR THROMBOSIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
213 |
2858839.78 |
CIR031 |
HYPOTENSION |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
57 |
841671.71 |
CIR032 |
OTHER SPECIFIED AND UNSPECIFIED CIRCULATORY DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
59 |
735311.05 |
CIR039 |
OTHER SPECIFIED DISEASES OF VEINS AND LYMPHATICS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
55 |
581441.21 |
DEN000 |
DENTAL DISEASES |
INJ000 |
INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
66 |
1145456.18 |
DEN000 |
DENTAL DISEASES |
MUS000 |
DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
29 |
500279.71 |
DEN001 |
ANY DENTAL CONDITION INCLUDING TRAUMATIC INJURY |
DEN002 |
NONTRAUMATIC DENTAL CONDITIONS |
DEN003 |
CARIES, PERIODONTITIS, AND OTHER PREVENTABLE DENTAL CONDS |
DIG002 |
DISORDERS OF TEETH AND GINGIVA |
249 |
4356072.86 |
DEN001 |
ANY DENTAL CONDITION INCLUDING TRAUMATIC INJURY |
DEN002 |
NONTRAUMATIC DENTAL CONDITIONS |
DEN003 |
CARIES, PERIODONTITIS, AND OTHER PREVENTABLE DENTAL CONDS |
FAC014 |
MEDICAL EXAMINATION/EVALUATION |
51 |
724846.02 |
DEN001 |
ANY DENTAL CONDITION INCLUDING TRAUMATIC INJURY |
DEN002 |
NONTRAUMATIC DENTAL CONDITIONS |
DIG002 |
DISORDERS OF TEETH AND GINGIVA |
-1 |
INAPPLICABLE |
84 |
1393350.44 |
DEN001 |
ANY DENTAL CONDITION INCLUDING TRAUMATIC INJURY |
DEN002 |
NONTRAUMATIC DENTAL CONDITIONS |
DIG003 |
DISEASES OF MOUTH; EXCLUDING DENTAL |
-1 |
INAPPLICABLE |
51 |
805444.11 |
DIG000 |
DISEASES OF THE DIGESTIVE SYSTEM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
290 |
5105307.01 |
DIG000 |
DISEASES OF THE DIGESTIVE SYSTEM |
INF000 |
CERTAIN INFECTIOUS AND PARASITIC DISEASES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
49 |
753956.26 |
DIG001 |
INTESTINAL INFECTION |
INF008 |
VIRAL INFECTION |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
99 |
1921659.04 |
DIG004 |
ESOPHAGEAL DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1245 |
18416548.39 |
DIG005 |
GASTRODUODENAL ULCER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
51 |
674257.17 |
DIG007 |
GASTRITIS AND DUODENITIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
88 |
1011163.41 |
DIG008 |
OTH SPECIFIED & UNSPECIFIED DISORDERS OF STOMACH & DUODEN |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
224 |
3098079.74 |
DIG010 |
ABDOMINAL HERNIA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
126 |
1883465.25 |
DIG011 |
REGIONAL ENTERITIS AND ULCERATIVE COLITIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
42 |
718269.11 |
DIG013 |
DIVERTICULOSIS AND DIVERTICULITIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
80 |
1178925.54 |
DIG014 |
HEMORRHOIDS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
58 |
853808.09 |
DIG017 |
BILIARY TRACT DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
48 |
807840.97 |
DIG019 |
OTHER SPECIFIED AND UNSPECIFIED LIVER DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
97 |
1708307.51 |
DIG020 |
PANCREATIC DISORDERS (EXCLUDING DIABETES) |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
40 |
649354.76 |
DIG022 |
NONINFECTIOUS GASTROENTERITIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
55 |
784715.18 |
DIG025 |
OTHER SPECIFIED AND UNSPECIFIED GASTROINTESTINAL DISORDER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
388 |
6096139.16 |
EAR000 |
DISEASES OF THE EAR AND MASTOID PROCESS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
96 |
1856316.45 |
EAR001 |
OTITIS MEDIA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
416 |
8403601.86 |
EAR004 |
HEARING LOSS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
261 |
3925284.14 |
EAR006 |
OTHER SPECIFIED AND UNSPECIFIED DISORDERS OF THE EAR |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
228 |
3528861.01 |
END000 |
ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
94 |
1593882.52 |
END000 |
ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES |
EYE000 |
DISEASES OF THE EYE AND ADNEXA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
28 |
300638.22 |
END000 |
ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES |
GEN000 |
DISEASES OF THE GENITOURINARY SYSTEM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
11 |
192759.68 |
END000 |
ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES |
SKN000 |
DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
6 |
85545.94 |
END001 |
THYROID DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1346 |
20339903.70 |
END002 |
DIABETES MELLITUS WITHOUT COMPLICATION |
END005 |
DIABETES MELLITUS, TYPE 2 |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1960 |
28241217.76 |
END003 |
DIABETES MELLITUS WITH COMPLICATION |
END005 |
DIABETES MELLITUS, TYPE 2 |
NVS020 |
OTH NERV SYS DISORDERS (NEITHER HEREDITARY OR DEGENERATIV |
-1 |
INAPPLICABLE |
49 |
563813.05 |
END007 |
NUTRITIONAL DEFICIENCIES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
579 |
8871298.81 |
END009 |
OBESITY |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
102 |
1723686.79 |
END010 |
DISORDERS OF LIPID METABOLISM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
3626 |
51947051.04 |
END011 |
FLUID AND ELECTROLYTE DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
312 |
4329316.97 |
END015 |
OTHER SPECIFIED AND UNSPECIFIED ENDOCRINE DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
239 |
4214864.85 |
END016 |
OTH SPECIFIED & UNSPEC NUTRITIONAL AND METABOLIC DISORDER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
150 |
2296064.23 |
EXT000 |
EXTERNAL CAUSES OF MORBIDITY |
INJ000 |
INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
15 |
216863.01 |
EXT000 |
EXTERNAL CAUSES OF MORBIDITY |
INJ000 |
INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU |
MBD000 |
MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS |
-1 |
INAPPLICABLE |
2 |
12773.85 |
EYE000 |
DISEASES OF THE EYE AND ADNEXA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
155 |
2395975.20 |
EYE001 |
CORNEA AND EXTERNAL DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
203 |
3960405.82 |
EYE002 |
CATARACT AND OTHER LENS DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
507 |
6467572.81 |
EYE003 |
GLAUCOMA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
320 |
4267725.91 |
EYE004 |
UVEITIS AND OCULAR INFLAMMATION |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
77 |
1109153.64 |
EYE005 |
RETINAL AND VITREOUS CONDITIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
320 |
4492756.09 |
EYE008 |
OCULOFACIAL PLASTICS AND ORBITAL CONDITIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
205 |
2768518.84 |
EYE009 |
REFRACTIVE ERROR |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
340 |
6345299.10 |
EYE010 |
BLINDNESS AND VISION DEFECTS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
206 |
3161407.97 |
EYE012 |
OTHER SPECIFIED EYE DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
154 |
2382641.46 |
FAC000 |
FACTORS INFLUENCING HEALTH STATUS & CONTACT W/ HEALTH SER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
312 |
5469833.13 |
FAC003 |
ENCTR FOR OBS, EXAM COND R/O, EXCL INFECT DIS, NPL, MENT |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
230 |
3664858.10 |
FAC005 |
ENCOUNTER FOR PROPHYLACTIC MEASURES (EXCLUDES IMMUNIZATIO |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
126 |
1979762.83 |
FAC008 |
NEOPLASM-RELATED ENCOUNTERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
255 |
3701289.87 |
FAC009 |
IMPLANT, DEVICE OR GRAFT RELATED ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
287 |
3996304.64 |
FAC010 |
OTHER AFTERCARE ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
121 |
1883164.59 |
FAC012 |
OTHER SPECIFIED ENCOUNTERS AND COUNSELING |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
450 |
7487675.86 |
FAC013 |
CONTRACEPTIVE AND PROCREATIVE MANAGEMENT |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
287 |
6172580.51 |
FAC014 |
MEDICAL EXAMINATION/EVALUATION |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
493 |
8819630.54 |
FAC016 |
EXPOSURE, ENCTR, SCREENING OR CONTACT W/ INFECTIOUS DISEA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
379 |
5646288.73 |
FAC019 |
SOCIOECONOMIC/PSYCHOSOCIAL FACTORS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
68 |
1243360.29 |
FAC022 |
ACQUIRED ABSENCE OF LIMB OR ORGAN |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
49 |
773163.85 |
FAC025 |
OTHER SPECIFIED STATUS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
462 |
6874623.14 |
GEN000 |
DISEASES OF THE GENITOURINARY SYSTEM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
381 |
6406902.17 |
GEN000 |
DISEASES OF THE GENITOURINARY SYSTEM |
INF000 |
CERTAIN INFECTIOUS AND PARASITIC DISEASES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
8 |
148817.46 |
GEN001 |
NEPHRITIS; NEPHROSIS; RENAL SCLEROSIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
43 |
621346.50 |
GEN002 |
ACUTE AND UNSPECIFIED RENAL FAILURE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
89 |
1181696.98 |
GEN003 |
CHRONIC KIDNEY DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
41 |
555190.10 |
GEN004 |
URINARY TRACT INFECTIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
569 |
8851421.38 |
GEN005 |
CALCULUS OF URINARY TRACT |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
167 |
2778669.76 |
GEN006 |
OTH SPECIFIED AND UNSPECIFIED DISEASES OF KIDNEY AND URET |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
211 |
2936519.35 |
GEN007 |
OTH SPECIFIED & UNSPECIFIED DISEASES OF BLADDER AND URETH |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
133 |
1844797.53 |
GEN008 |
URINARY INCONTINENCE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
139 |
1832398.79 |
GEN012 |
HYPERPLASIA OF PROSTATE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
280 |
3851695.87 |
GEN014 |
ERECTILE DYSFUNCTION |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
76 |
1176031.41 |
GEN016 |
OTHER SPECIFIED MALE GENITAL DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
99 |
1296608.50 |
GEN017 |
NONMALIGNANT BREAST CONDITIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
139 |
2124432.25 |
GEN018 |
INFLAMMATORY DISEASES OF FEMALE PELVIC ORGANS |
GEN025 |
OTHER SPECIFIED FEMALE GENITAL DISORDERS |
INF004 |
FUNGAL INFECTIONS |
-1 |
INAPPLICABLE |
44 |
716367.90 |
GEN021 |
MENSTRUAL DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
47 |
971322.78 |
GEN022 |
BENIGN OVARIAN CYST |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
44 |
705359.80 |
GEN025 |
OTHER SPECIFIED FEMALE GENITAL DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
108 |
1618749.14 |
INF000 |
CERTAIN INFECTIOUS AND PARASITIC DISEASES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
261 |
4002829.46 |
INF000 |
CERTAIN INFECTIOUS AND PARASITIC DISEASES |
MUS000 |
DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
4 |
50787.12 |
INF000 |
CERTAIN INFECTIOUS AND PARASITIC DISEASES |
RSP000 |
DISEASES OF THE RESPIRATORY SYSTEM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
8 |
174895.13 |
INF000 |
CERTAIN INFECTIOUS AND PARASITIC DISEASES |
SKN000 |
DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
2 |
22699.34 |
INF003 |
BACTERIAL INFECTIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
91 |
1711816.77 |
INF003 |
BACTERIAL INFECTIONS |
RSP006 |
OTHER SPECIFIED UPPER RESPIRATORY INFECTIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
343 |
7282865.37 |
INF004 |
FUNGAL INFECTIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
115 |
1746357.18 |
INF008 |
VIRAL INFECTION |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
228 |
4376199.00 |
INF008 |
VIRAL INFECTION |
SKN007 |
OTHER SPECIFIED AND UNSPECIFIED SKIN DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
91 |
1370651.69 |
INF009 |
PARASITIC, OTHER SPECIFIED AND UNSPECIFIED INFECTIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
54 |
777067.25 |
INF012 |
CORONAVIRUS DISEASE - 2019 (COVID-19) |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
724 |
12135275.88 |
INJ000 |
INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
351 |
5718315.49 |
INJ000 |
INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU |
MBD000 |
MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
5 |
63649.41 |
INJ000 |
INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU |
NVS000 |
DISEASES OF THE NERVOUS SYSTEM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
2 |
26718.19 |
INJ000 |
INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU |
SKN000 |
DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
35 |
735413.96 |
INJ031 |
ALLERGIC REACTIONS |
RSP007 |
OTHER SPECIFIED AND UNSPECIFIED UPPER RESPIRATORY DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
887 |
13446090.69 |
INJ031 |
ALLERGIC REACTIONS |
SKN005 |
CONTACT DERMATITIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
97 |
1599080.19 |
INJ031 |
ALLERGIC REACTIONS |
SKN007 |
OTHER SPECIFIED AND UNSPECIFIED SKIN DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
210 |
3803279.08 |
INJ039 |
FRACTURE OF THE SPINE AND BACK, SUBSEQUENT ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
45 |
700078.20 |
INJ041 |
FRACTURE OF THE UPPER LIMB, SUBSEQUENT ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
144 |
2502834.20 |
INJ042 |
FRACTURE OF LOWER LIMB (EXCEPT HIP), SUBSEQUENT ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
142 |
2361580.78 |
INJ045 |
TRAUMATIC BRAIN INJURY (TBI); CONCUSSION, SUBSEQUENT ENCT |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
66 |
1332312.91 |
INJ049 |
OPEN WOUNDS TO LIMBS, SUBSEQUENT ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
64 |
1055343.27 |
INJ054 |
SUPERFICIAL INJURY; CONTUSION, SUBSEQUENT ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
55 |
1002592.96 |
INJ060 |
TOXIC EFFECTS, SUBSEQUENT ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
59 |
844446.41 |
INJ061 |
SPRAINS AND STRAINS, SUBSEQUENT ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
394 |
7256075.53 |
INJ064 |
OTHER UNSPECIFIED INJURIES, SUBSEQUENT ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
753 |
12251408.04 |
INJ067 |
ALLERGIC REACTIONS, SUBSEQUENT ENCOUNTER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
250 |
3677846.61 |
INJ072 |
COMPLC OF OTHER SURGICAL/MEDICAL CARE, INJURY, SUBSEQ ENC |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
44 |
625307.28 |
MAL000 |
CONGENITAL MALFORMATIONS, DEFORMATIONS & CHROMOSOMAL ABNO |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
73 |
1587099.56 |
MAL001 |
CARDIAC AND CIRCULATORY CONGENITAL ANOMALIES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
42 |
875844.69 |
MBD000 |
MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
328 |
5731054.31 |
MBD000 |
MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS |
PRG000 |
PREGNANCY, CHILDBIRTH AND THE PUERPERIUM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
24 |
489718.24 |
MBD001 |
SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
44 |
631077.38 |
MBD002 |
DEPRESSIVE DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1557 |
26326011.15 |
MBD003 |
BIPOLAR AND RELATED DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
180 |
2840325.45 |
MBD004 |
OTHER SPECIFIED AND UNSPECIFIED MOOD DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
49 |
706918.63 |
MBD005 |
ANXIETY AND FEAR-RELATED DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1791 |
30722316.44 |
MBD007 |
TRAUMA- AND STRESSOR-RELATED DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
402 |
6941095.07 |
MBD013 |
MISCELLANEOUS MENTAL AND BEHAVIORAL DISORDERS/CONDITIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
243 |
4508424.61 |
MBD014 |
NEURODEVELOPMENTAL DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
773 |
15092693.51 |
MBD025 |
OTHER SPECIFIED SUBSTANCE-RELATED DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
52 |
777045.88 |
MUS000 |
DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
351 |
5818208.38 |
MUS000 |
DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS |
SKN000 |
DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
31 |
553322.05 |
MUS003 |
RHEUMATOID ARTHRITIS AND RELATED DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
332 |
4626607.72 |
MUS006 |
OSTEOARTHRITIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1345 |
18748068.22 |
MUS007 |
OTHER SPECIFIED JOINT DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
195 |
2808681.65 |
MUS009 |
TENDON AND SYNOVIAL DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
248 |
3529739.80 |
MUS010 |
MUSCULOSKELETAL PAIN, NOT LOW BACK PAIN |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
2557 |
38869178.58 |
MUS011 |
SPONDYLOPATHIES/SPONDYLOARTHROPATHY (INCLUDING INFECTIVE) |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
621 |
8809722.44 |
MUS011 |
SPONDYLOPATHIES/SPONDYLOARTHROPATHY (INCLUDING INFECTIVE) |
MUS038 |
LOW BACK PAIN |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
421 |
5924468.29 |
MUS013 |
OSTEOPOROSIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
170 |
2199332.08 |
MUS021 |
ACQUIRED FOOT DEFORMITIES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
67 |
936380.00 |
MUS022 |
SCOLIOSIS AND OTHER POSTURAL DORSOPATHIC DEFORMITIES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
69 |
1159489.72 |
MUS024 |
SYSTEMIC LUPUS ERYTHEMATOSUS AND CONNECTIVE TISSUE DISORD |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
44 |
715087.60 |
MUS025 |
OTHER SPECIFIED CONNECTIVE TISSUE DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
579 |
8121677.26 |
MUS026 |
MUSCLE DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
120 |
1801655.73 |
MUS028 |
OTHER SPECIFIED BONE DISEASE AND MUSCULOSKELETAL DEFORMIT |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
197 |
2582710.75 |
MUS033 |
GOUT |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
228 |
3279156.10 |
MUS038 |
LOW BACK PAIN |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
350 |
5120670.28 |
NEO000 |
NEOPLASMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
273 |
4075533.75 |
NEO015 |
GASTROINTESTINAL CANCERS - COLORECTAL |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
44 |
644341.00 |
NEO022 |
RESPIRATORY CANCERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
42 |
599230.89 |
NEO025 |
SKIN CANCERS - MELANOMA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
119 |
1803304.51 |
NEO026 |
SKIN CANCERS - BASAL CELL CARCINOMA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
48 |
706997.34 |
NEO027 |
SKIN CANCERS - SQUAMOUS CELL CARCINOMA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
40 |
596043.56 |
NEO028 |
SKIN CANCERS - ALL OTHER TYPES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
373 |
5290123.49 |
NEO030 |
BREAST CANCER - ALL OTHER TYPES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
189 |
2589736.64 |
NEO039 |
MALE REPRODUCTIVE SYSTEM CANCERS - PROSTATE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
156 |
2101732.44 |
NEO043 |
URINARY SYSTEM CANCERS - BLADDER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
46 |
679301.94 |
NEO050 |
ENDOCRINE SYSTEM CANCERS - THYROID |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
49 |
725908.24 |
NEO064 |
LEUKEMIA - ALL OTHER TYPES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
46 |
590810.83 |
NEO072 |
NEOPLASMS OF UNSPECIFIED NATURE OR UNCERTAIN BEHAVIOR |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
136 |
2118823.20 |
NEO073 |
BENIGN NEOPLASMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
274 |
4371130.88 |
NVS000 |
DISEASES OF THE NERVOUS SYSTEM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
233 |
3569828.18 |
NVS000 |
DISEASES OF THE NERVOUS SYSTEM |
SYM000 |
SYMPTOMS, SIGNS AND ABNORMAL CLINICAL & LAB FINDINGS, NEC |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
2 |
60004.24 |
NVS004 |
PARKINSON'S DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
53 |
704700.61 |
NVS006 |
OTHER NERV SYS DISORDERS (OFTEN HEREDITARY OR DEGENERATIV |
NVS016 |
SLEEP WAKE DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
118 |
1536461.15 |
NVS009 |
EPILEPSY; CONVULSIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
168 |
2508342.25 |
NVS010 |
HEADACHE; INCLUDING MIGRAINE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
374 |
6889826.48 |
NVS010 |
HEADACHE; INCLUDING MIGRAINE |
SYM010 |
NERVOUS SYSTEM SIGNS AND SYMPTOMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
130 |
1931297.19 |
NVS011 |
NEUROCOGNITIVE DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
72 |
928744.38 |
NVS012 |
TRANSIENT CEREBRAL ISCHEMIA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
256 |
3365001.54 |
NVS015 |
POLYNEUROPATHIES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
183 |
2770474.15 |
NVS016 |
SLEEP WAKE DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1089 |
15760382.16 |
NVS017 |
NERVE AND NERVE ROOT DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
246 |
3869217.68 |
NVS019 |
NERVOUS SYSTEM PAIN AND PAIN SYNDROMES |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
254 |
3768854.16 |
NVS020 |
OTH NERV SYS DISORDERS (NEITHER HEREDITARY OR DEGENERATIV |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
42 |
775986.37 |
PNL000 |
CERTAIN CONDITIONS ORIGINATING IN THE PERINATAL PERIOD |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
12 |
317741.40 |
PNL001 |
LIVEBORN |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
42 |
1050966.49 |
PRG000 |
PREGNANCY, CHILDBIRTH AND THE PUERPERIUM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
103 |
1950958.11 |
PRG029 |
UNCOMPLICATED PREGNANCY, DELIVERY OR PUERPERIUM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
218 |
4011462.90 |
RSP000 |
DISEASES OF THE RESPIRATORY SYSTEM |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
126 |
2155235.32 |
RSP001 |
SINUSITIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
450 |
7882738.78 |
RSP002 |
PNEUMONIA (EXCEPT THAT CAUSED BY TUBERCULOSIS) |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
210 |
3280684.42 |
RSP003 |
INFLUENZA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
195 |
3788370.05 |
RSP004 |
ACUTE AND CHRONIC TONSILLITIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
69 |
1332618.68 |
RSP005 |
ACUTE BRONCHITIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
184 |
3195752.78 |
RSP006 |
OTHER SPECIFIED UPPER RESPIRATORY INFECTIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
472 |
9135780.66 |
RSP007 |
OTHER SPECIFIED AND UNSPECIFIED UPPER RESPIRATORY DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
207 |
3390489.54 |
RSP008 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND BRONCHIECTASIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
381 |
5154250.58 |
RSP009 |
ASTHMA |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
1212 |
18970988.17 |
RSP016 |
OTHER SPECIFIED AND UNSPECIFIED LOWER RESPIRATORY DISEASE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
185 |
3060522.26 |
SKN000 |
DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
73 |
1181270.13 |
SKN001 |
SKIN AND SUBCUTANEOUS TISSUE INFECTIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
248 |
3983628.89 |
SKN002 |
OTHER SPECIFIED INFLAMMATORY CONDITION OF SKIN |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
432 |
7658855.63 |
SKN007 |
OTHER SPECIFIED AND UNSPECIFIED SKIN DISORDERS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
859 |
12834903.95 |
SYM000 |
SYMPTOMS, SIGNS AND ABNORMAL CLINICAL & LAB FINDINGS, NEC |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
336 |
5226103.48 |
SYM002 |
FEVER |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
118 |
2142663.43 |
SYM004 |
NAUSEA AND VOMITING |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
258 |
4223063.81 |
SYM006 |
ABDOMINAL PAIN & OTHER DIGESTIVE/ABDOMEN SIGNS AND SYMPTO |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
467 |
7131560.68 |
SYM007 |
MALAISE AND FATIGUE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
88 |
1306295.35 |
SYM008 |
SYMPTOMS OF MENTAL AND SUBSTANCE USE CONDITIONS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
49 |
832338.18 |
SYM010 |
NERVOUS SYSTEM SIGNS AND SYMPTOMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
318 |
4706216.75 |
SYM011 |
GENITOURINARY SIGNS AND SYMPTOMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
202 |
3050202.73 |
SYM012 |
CIRCULATORY SIGNS AND SYMPTOMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
309 |
4311485.86 |
SYM013 |
RESPIRATORY SIGNS AND SYMPTOMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
561 |
8869076.57 |
SYM014 |
SKIN/SUBCUTANEOUS SIGNS AND SYMPTOMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
313 |
4869533.16 |
SYM015 |
GENERAL SENSATION/PERCEPTION SIGNS AND SYMPTOMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
223 |
3050680.38 |
SYM016 |
OTHER GENERAL SIGNS AND SYMPTOMS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
681 |
9798277.78 |
SYM017 |
ABNORMAL FINDINGS WITHOUT DIAGNOSIS |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
-1 |
INAPPLICABLE |
460 |
7170306.48 |
|
|
|
|
|
|
|
|
63656 |
987503811.33 |
Return To Table Of Contents
|